The Collaboration for Oncology Data in Europe (CODE) sponsors the Value of Data in Oncology Conference on 5 June, Bucharest, Romania

Read More

Dr. Ashley Woolmore, Senior Vice President, Head of European Data and Evidence Networks, and CODE Lead at IQVIA will be speaking at the Value of Data in Oncology conference in Bucharest, Romania on 5 June 2019 which CODE is also sponsoring.  This conference is being held in the context of the Romanian EU Council Presidency.

Organised by the Centre for Innovation in Medicine, the event’s goal is to define a new vision for strategies that tackle cancer and support the objectives set out by the European Commission. These objectives were defined by Martin Seychell, Deputy Director-General for Consumers and Health: “By boosting research and cooperation, we can ensure that efficient treatments are developed to treat cancer patients across the EU…[and] by raising awareness about cancer prevention our ambitious goal is to reduce new cancer cases by 15% by 2020”1. The Centre for Innovation in Medicine will be proposing the development of an EU cancer plan focused on “data”, “technologies” and “human intelligence”.

“There is an increasing need to focus efforts at a European level to tackle the rising incidence of cancer. With this event, the Centre for Innovation in Medicine aims to bring the oncology community together and develop a next-level digital approach to meeting the goals of the European Commission.” – Marius Geanta, President and Co-Found at the Centre for Innovation in Medicine

Dr. Woolmore has been invited to speak as a panellist on the topic of “Capturing the real perspective on cancer in the healthcare systems across Europe.” He will be sharing CODE’s vision of addressing key challenges in the oncology community by providing near real-time data at scale. He will also describe why we have chosen to build the Oncology Data Network (ODN) to support this vision by providing access to high quality clinical data which is analytically available for research.

 “Part of the value of data in oncology comes from the actionability of insights drawn from a systematic and large-scale collaborative network. These insights have greater power to inform quality, innovation and value in cancer care if they are describing ‘today’s treatment’. Understanding where we are today can help us shape cancer care in the future.  I am delighted to have an opportunity to contribute to this important discussion and support this event.” – Dr. Ashley Woolmore, Senior Vice President, Head of European Data and Evidence Networks, and CODE Lead at IQVIA

To learn more about how our work with CODE and the ODN are aligned with EU cancer objectives, please contact Julia Levy, Julia.Levy@iqvia.com.

  1. Seychell, Martin. “Cancer.” Health-EU Newsletter 122 – Focus: Cancer, European Commission, ec.europa.eu/health/newsletter/122/focus_newsletter_en.htm.

One hundred hospitals and growing: the Oncology Data Network celebrates major milestone

Read More

The Oncology Data Network (ODN), a pioneering collaborative network for European cancer treatment centres, has reached an important milestone. The Network has now grown to 100 hospitals across six countries. The centres involved in the Network are providing cancer treatment to some 60,000 people with cancer. This strong growth has been accomplished since the initiative was launched at the European Society for Medical Oncology Congress (ESMO) 2017.

The Oncology Data Network is open to all centres who are treating cancer patients and its aim is to become an invaluable resource for the European cancer community. In line with that goal, the near-term ambition is for the Network to double in size in the next 12 months.

The value of the Oncology Data Network increases as the number of centres who are joining increases. As one of the ODN members, Dr Enrique Grande, Head of the Medical Oncology Service at MD Anderson Hospital in Spain said,

“Undoubtedly, initiatives such as the ODN help to improve the quality of care in cancer treatment and are a great step forward in terms of innovation.”

Ashley Woolmore, who is leading the ODN initiative added,

“This is a significant achievement and we give our sincere thanks to the 100 centres who have joined the Network. This would not have been possible either without the help of our international clinical advisors on the Clinical and Analytical Steering Group, the members of our Country Advisory Groups as well as each and every person involved in CODE.

If you are interested in joining the ODN, please contact us.

100 Network members and growing